CN1330361C - Chinese medicine special for treating chronic atrophic gastritis - Google Patents
Chinese medicine special for treating chronic atrophic gastritis Download PDFInfo
- Publication number
- CN1330361C CN1330361C CNB2004100438440A CN200410043844A CN1330361C CN 1330361 C CN1330361 C CN 1330361C CN B2004100438440 A CNB2004100438440 A CN B2004100438440A CN 200410043844 A CN200410043844 A CN 200410043844A CN 1330361 C CN1330361 C CN 1330361C
- Authority
- CN
- China
- Prior art keywords
- weight portions
- atrophic gastritis
- radix
- chinese medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000016644 chronic atrophic gastritis Diseases 0.000 title claims abstract description 41
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 238000011282 treatment Methods 0.000 claims description 46
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 15
- 210000003038 endothelium Anatomy 0.000 claims description 15
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 15
- 239000010271 massa medicata fermentata Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 235000009508 confectionery Nutrition 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 241000411851 herbal medicine Species 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 9
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 7
- 208000004300 Atrophic Gastritis Diseases 0.000 abstract description 6
- 208000036495 Gastritis atrophic Diseases 0.000 abstract description 6
- 230000001684 chronic effect Effects 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 34
- 230000007170 pathology Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 230000006872 improvement Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000234314 Zingiber Species 0.000 description 5
- 235000006886 Zingiber officinale Nutrition 0.000 description 5
- 230000004596 appetite loss Effects 0.000 description 5
- 238000001574 biopsy Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 206010017758 gastric cancer Diseases 0.000 description 5
- 210000001156 gastric mucosa Anatomy 0.000 description 5
- 235000008397 ginger Nutrition 0.000 description 5
- 208000019017 loss of appetite Diseases 0.000 description 5
- 235000021266 loss of appetite Nutrition 0.000 description 5
- 201000011549 stomach cancer Diseases 0.000 description 5
- 206010054949 Metaplasia Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 206010020718 hyperplasia Diseases 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 230000015689 metaplastic ossification Effects 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000003902 lesion Effects 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 238000002575 gastroscopy Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004682 mucosal barrier function Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a traditional Chinese medicine special for treating chronic atrophic gastritis and a preparation method thereof. The chronic atrophic gastritis is the potential factor of stomach cancers, and the chronic severe atrophic gastritis is one mutation in the prior period of stomach cancers. No medicine special for treating chronic atrophic gastritis exists at home and abroad at present. The traditional Chinese medicine special for treating chronic atrophic gastritis is prepared from 15 to 30 weight portions of herba artemisiae, 5 to 15 weight portions of rhubarb, 5 to 12 weight portions of liquorice, 9 to 15 weight portions of tuckahoe, 5 to 10 weight portions of pinellia tuber, 13 to 30 weight portions of baikal skullcap, 5 to 10 weight portions of nutgrass galingale rhizome, 15 to 20 weight portions of immature orange fruit, 12 to 50 weight portions of largehead atractylodes rhizome, 5 to 30 weight portions of officinal magnolia bark, 15 to 25 weight portions of chicken's gizzard-membrane, 20 to 30 weight portions of dried tangerine peel, 10 to 25 weight portions of radish, 25 to 50 weight portions of malt, 25 to 55 weight portions of medicated leaven and 50 to 100 weight portions of parched hawthorn fruit. The product is used for treating chronic atrophic gastritis.
Description
Technical field: the present invention relates to special-purpose Chinese medicine of a kind of treatment chronic atrophic gastritis and preparation method thereof.
Background technology: because popularizing of gastroscope in recent years, cooperate pathologic finding after, the patient who finds to suffer from chronic atrophic gastritis is more.According to the literature: " chronic atrophic gastritis is the factor of hiding of gastric cancer, and especially chronic severe atrophic gastritis is to belong to one of gastric precancerous lesion ".So prevent and treat chronic atrophic gastritis is the key that reduces the incidence gastric cancer rate.The present domestic special-purpose medicaments that does not still have a kind of special for treating chronic atrophic gastritis.
Summary of the invention: the purpose of this invention is to provide a kind of good effect, manufacture method is simply treated special-purpose Chinese medicine of chronic atrophic gastritis and preparation method thereof.
Above-mentioned purpose realizes by following technical scheme:
The special-purpose Chinese medicine of treatment chronic atrophic gastritis, its composition comprises: Herba Artemisiae Scopariae, also comprise Radix Et Rhizoma Rhei in the described Chinese medicine, Radix Glycyrrhizae, Poria, the Rhizoma Pinelliae, Radix Scutellariae, Rhizoma Cyperi, Fructus Aurantii Immaturus, the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae, Radix Raphani, Fructus Hordei Germinatus, Massa Medicata Fermentata, Fructus Crataegi (parched to brown), its ratio of weight and number are Herba Artemisiae Scopariae 15～30, Radix Et Rhizoma Rhei 5～15, Radix Glycyrrhizae 5～12, Poria 9～15, the Rhizoma Pinelliae 5～10, Radix Scutellariae 13～30, Rhizoma Cyperi 5～10, Fructus Aurantii Immaturus 15～20, the Rhizoma Atractylodis Macrocephalae 12～50, Cortex Magnoliae Officinalis 5～30, Endothelium Corneum Gigeriae Galli 15～25, Pericarpium Citri Reticulatae 20～30, Radix Raphani 10～25, Fructus Hordei Germinatus 25～50, Massa Medicata Fermentata 25～55, Fructus Crataegi (parched to brown) 50～100.
The manufacture method of the special-purpose Chinese medicine of above-mentioned treatment chronic atrophic gastritis, get Herba Artemisiae Scopariae 15～30 by above-mentioned described ratio of weight and number, Radix Et Rhizoma Rhei 5～15, Radix Glycyrrhizae 5～12, Poria 9～15, the Rhizoma Pinelliae 5～10, Radix Scutellariae 13～30, Rhizoma Cyperi 5～10, Fructus Aurantii Immaturus 15～20, the Rhizoma Atractylodis Macrocephalae 12～50, Cortex Magnoliae Officinalis 5～30, Endothelium Corneum Gigeriae Galli 15～25, Pericarpium Citri Reticulatae 20～30, Radix Raphani 10～25, Fructus Hordei Germinatus 25～50, Massa Medicata Fermentata 25～55, Fructus Crataegi (parched to brown) 50～100, with each flavor Chinese medicine oven dry, bake out temperature is 60～80 ℃, be ground into fine flour afterwards, mix and add therein Mel, at 100～120 ℃ of refined honeys, cool to 80～100 ℃, make sweet face mix homogeneously, every ball 9 grams, take secondary every day, each two balls, treating 50 days is a course of treatment.
This technical scheme has following beneficial effect:
1. chronic atrophic gastritis is China's frequently-occurring disease commonly encountered diseases, and is one of gastric precancerous lesion, is the factor of hiding that gastric cancer takes place, and is to cut off the key that gastric cancer takes place so prevent and treat chronic atrophic gastritis.The special-purpose Chinese medicine of treatment chronic atrophic gastritis of the present invention, select pure Chinese medicine for use, through the science compatibility, chronic light, moderate atrophic gastritis had promote the newborn effect that pathological changes is reversed of repairing of gastric mucosa, can prevent canceration to chronic severe atrophic gastritis and gastratrophia, and can eliminate the stifled pain of precordial region, belch, anorexia, full feeling, symptom such as indigestion and loss of appetite rapidly, and can appetite stimulator, be the choice drug for the treatment of chronic atrophic gastritis the present age.
2. chronic atrophic gastritis is divided into the AB amphitypy, the Asia yellow race is the Type B atrophic gastritis in general, many because long-term anti-stream, smoking, drink, medicine or factors such as various chronic gastritis, gastric ulcer, the destruction that causes gastric mucosal barrier and gastric mucosa layer, add the effect of helicobacter pylori, the body of gland of gastric mucosa is reduced relatively, and with in various degree intestinal epithelial metaplasia, atypical hyperplasia, body of gland cystic lesion etc., and replace the structure of normal gastric mucosa, cause that gastric acid, pepsinia reduce, form low sour gastropathy, canceration easily takes place.Therefore treating chronic atrophic gastritis is the important step of preventing and treating gastric cancer.The mutual compatibility of Chinese medicine Herba Artemisiae Scopariae, Radix Et Rhizoma Rhei, Radix Glycyrrhizae, Poria, the Rhizoma Pinelliae, Radix Scutellariae that the present invention is selected, has stronger clearing away heat-damp and promoting diuresis effect, symptoms such as stomachache distension, weakness of the spleen and stomach, drying dampness to eliminate phlegm, stomach function regulating preventing or arresting vomiting, chest and diaphragm distension had splendid curative effect, and have the adjusting of promotion to improve gastric secretion, adjust effects such as gastric motility.
3. chronic atrophic gastritis is a kind of frequently-occurring disease commonly encountered diseases, and its main clinical manifestation is the stifled pain of precordial region, full feeling, belch, indigestion and loss of appetite, symptom such as yellowish complexion is become thin, thick fur is bored with.Selected Chinese medicine Rhizoma Cyperi, Fructus Aurantii Immaturus, the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae, Radix Raphani, Fructus Hordei Germinatus, Massa Medicata Fermentata and the Fructus Crataegi (parched to brown) of the present invention is compatible, depressed liver-energy dispersing and QI regulating, invigorating the spleen and benefiting QI, spleen invigorating removing food stagnancy are arranged preferably, help digestion and medium effect, can effectively regulate and promote replenishing gastric acid, pepsic secretion, and can alleviate clinical symptoms such as breast abdomen stagnation of QI distending pain, constipation, diarrhea due to hypofunction of the spleen, food stagnation abdominal distention, dispersing the stagnated live-QI to relieve the stagnation of QI, dyspeptic abdominal distention, dyspepsia rapidly, appetite stimulator, weight increase recovers the body vigor.
4. take this product light moderate atrophic gastritis is had the newborn reparation of the gastric mucosa of promotion, the effect that pathological changes is reversed, the biopsy pathology section is carried out in patient's gastroscopy of 388 routine chronic atrophic gastritis simultaneously, after wherein having 126 routine patients (account for sum 20.5%) to take 50 days (course of treatment) of this medicine treatment, carry out the gastroscope check, its pathological change situation is observed in biopsy, and statistical result shows: intestinal epithelial metaplasia I～II
0Treat preceding 324 examples, account for 83.5% of total number of persons, wherein have pathology to improve after the 63 example treatments, account for 50% of treatment number; To atypical hyperplasia I～II
0Preceding 64 examples of sick treatment account for 16.5% of sum, and pathology 60 examples that made moderate progress in treatment back account for total 47.6%; Do not improve having before the no change pathology treatment, have 3 routine no change pathology to improve after the treatment, account for 2.38% of sum.Have 126 routine patients to take " WEILEXIN CHONGJI ", the biopsy number is that 52 examples account for 41.3%, and statistical result shows: intestinal epithelial metaplasia I～II
0Treat preceding 25 examples, account for 48.1% of total number of persons, wherein have pathology to improve after the 36 example treatments, account for 48.65% of treatment number; To atypical hyperplasia I～II
0Preceding 24 examples of sick treatment account for 46.15% of sum, and pathology 38 examples that made moderate progress in treatment back account for total 51.35%; No case before the no change pathology treatment is improved, 3 examples are arranged after the treatment, account for 5.77% of sum.
5 these Chinese medicine applying clinicals are over more than 20 year, and treatment chronic atrophic gastritis 1889 examples have significant curative effect, and are nontoxic, have no side effect, and the value of promoting the use of is arranged clinically.
6. the chronic atrophic gastritis patient who makes a definite diagnosis is divided into two groups at random, wherein 1889 examples are treated with this medicine, each two ball of twice morning and evening of every day, and the ginger decoction water delivery service 50 days was a course of treatment; Another is organized 1552 examples and takes " WEILEXIN CHONGJI " treatment, every day three times, one bag of ante cibum, warm boiled water, 50 days is a course of treatment, takes this medicine man 590 examples, account for 31.23% of total number of persons, woman's 1299 examples account for 68.7% of total number of persons, add up to 1889 examples, account for 54.9% of total number of persons, mean age is 43.8 years old, and patient's 1719 examples of the stifled pain of pit of the stomach symptom are arranged, and its symptom has and significantly accounts for 91%; Patient's 1619 examples of full feeling symptom are arranged, and what its symptom had clear improvement accounts for 85.7%; Patient's 1606 examples of belch symptom are arranged, and what its symptom had clear improvement accounts for 85%; Patient's 1409 examples of indigestion and loss of appetite symptom are arranged, and what its symptom had clear improvement accounts for 74.6%; Become thin patient's 1020 examples of symptom of yellowish complexion are arranged, and what its symptom had clear improvement accounts for 54%; And take " WEILEXIN CHONGJI " treatment, male 295 examples account for 19% of total number of persons, women 1257 examples, account for 81% of total number of persons, add up to 1552 examples, account for 45.1% of total number of persons, mean age is 45.3 years old, and patient's 1133 examples of the stifled pain of pit of the stomach symptom are arranged, and its symptom has and significantly accounts for 73%; Patient's 1070 examples of full feeling symptom are arranged, and what its symptom had clear improvement accounts for 69%; Patient's 1164 examples of belch symptom are arranged, and what its symptom had clear improvement accounts for 75%; Patient's 745 examples of indigestion and loss of appetite symptom are arranged, and what its symptom had clear improvement accounts for 48%; Become thin patient's 295 examples of symptom of yellowish complexion are arranged, and what its symptom had clear improvement accounts for 19%.The data analysis contrast that provides by above, it is better to take this drug effect fruit, and better efficacy can be prevented canceration preferably.
7. the manufacture method of the special-purpose Chinese medicine of treatment chronic atrophic gastritis of the present invention, simple, operation easily, made honeyed pill quality reaches " Chinese pharmacopoeia (an one) standard.
The specific embodiment of the present invention:
Embodiment 1:
Special-purpose Chinese medicine of treatment chronic atrophic gastritis and preparation method thereof, its composition comprises: Herba Artemisiae Scopariae, also comprise Radix Et Rhizoma Rhei in the described Chinese medicine, Radix Glycyrrhizae, Poria, the Rhizoma Pinelliae, Radix Scutellariae, Rhizoma Cyperi, Fructus Aurantii Immaturus, the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae, Radix Raphani, Fructus Hordei Germinatus, Massa Medicata Fermentata, Fructus Crataegi (parched to brown), its ratio of weight and number is a Herba Artemisiae Scopariae 15, Radix Et Rhizoma Rhei 5, Radix Glycyrrhizae 5, Poria 9, the Rhizoma Pinelliae 5, Radix Scutellariae 13, Rhizoma Cyperi 5, Fructus Aurantii Immaturus 15, the Rhizoma Atractylodis Macrocephalae 12, Cortex Magnoliae Officinalis 5, Endothelium Corneum Gigeriae Galli 15, Pericarpium Citri Reticulatae 20, Radix Raphani 10, Fructus Hordei Germinatus 25, Massa Medicata Fermentata 25, Fructus Crataegi (parched to brown) 50, its manufacture method is: get Herba Artemisiae Scopariae 15 by above-mentioned described ratio of weight and number, Radix Et Rhizoma Rhei 5, Radix Glycyrrhizae 5, Poria 9, the Rhizoma Pinelliae 5, Radix Scutellariae 13, Rhizoma Cyperi 5, Fructus Aurantii Immaturus 15, the Rhizoma Atractylodis Macrocephalae 12, Cortex Magnoliae Officinalis 5, Endothelium Corneum Gigeriae Galli 15, Pericarpium Citri Reticulatae 20, Radix Raphani 10, Fructus Hordei Germinatus 25, Massa Medicata Fermentata 25, Fructus Crataegi (parched to brown) 50, with each flavor Chinese medicine oven dry, bake out temperature is 60 ℃, be ground into fine flour afterwards, mix and add therein Mel, at 100 ℃ of refined honeys, cool to 80 ℃, make sweet face mix homogeneously, make honeyed pill by the Chinese Pharmacopoeia requirement, every ball 9 grams, each clothes two balls, ante cibum morning, with warm water delivery service (is that drink can improve curative effect with the ginger decoction), treating 50 days is a course of treatment after the supper.
Embodiment 2:
Special-purpose Chinese medicine of treatment chronic atrophic gastritis and preparation method thereof, its composition comprises: Herba Artemisiae Scopariae, also comprise Radix Et Rhizoma Rhei in the described Chinese medicine, Radix Glycyrrhizae, Poria, the Rhizoma Pinelliae, Radix Scutellariae, Rhizoma Cyperi, Fructus Aurantii Immaturus, the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae, Radix Raphani, Fructus Hordei Germinatus, Massa Medicata Fermentata, Fructus Crataegi (parched to brown), its ratio of weight and number is a Herba Artemisiae Scopariae 30, Radix Et Rhizoma Rhei 15, Radix Glycyrrhizae 12, Poria 15, the Rhizoma Pinelliae 10, Radix Scutellariae 30, Rhizoma Cyperi 10, Fructus Aurantii Immaturus 20, the Rhizoma Atractylodis Macrocephalae 50, Cortex Magnoliae Officinalis 30, Endothelium Corneum Gigeriae Galli 25, Pericarpium Citri Reticulatae 30, Radix Raphani 25, Fructus Hordei Germinatus 50, Massa Medicata Fermentata 55, Fructus Crataegi (parched to brown) 100, its manufacture method is: get Herba Artemisiae Scopariae 30 by above-mentioned described ratio of weight and number, Radix Et Rhizoma Rhei 15, Radix Glycyrrhizae 12, Poria 15, the Rhizoma Pinelliae 10, Radix Scutellariae 30, Rhizoma Cyperi 10, Fructus Aurantii Immaturus 20, the Rhizoma Atractylodis Macrocephalae 50, Cortex Magnoliae Officinalis 30, Endothelium Corneum Gigeriae Galli 25, Pericarpium Citri Reticulatae 30, Radix Raphani 25, Fructus Hordei Germinatus 50, Massa Medicata Fermentata 55, Fructus Crataegi (parched to brown) 100, with each flavor Chinese medicine oven dry, bake out temperature is 80 ℃, be ground into fine flour afterwards, mix and add therein Mel, at 120 ℃ of refined honeys, cool to 100 ℃, make sweet face mix homogeneously, make honeyed pill by the Chinese Pharmacopoeia requirement, every ball 9 grams, each clothes two balls, ante cibum morning, with warm water delivery service (is that drink can improve curative effect with the ginger decoction), treating 50 days is a course of treatment after the supper.
Embodiment 3:
Special-purpose Chinese medicine of treatment chronic atrophic gastritis and preparation method thereof, its composition comprises: Herba Artemisiae Scopariae, also comprise Radix Et Rhizoma Rhei in the described Chinese medicine, Radix Glycyrrhizae, Poria, the Rhizoma Pinelliae, Radix Scutellariae, Rhizoma Cyperi, Fructus Aurantii Immaturus, the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae, Radix Raphani, Fructus Hordei Germinatus, Massa Medicata Fermentata, Fructus Crataegi (parched to brown), its ratio of weight and number is a Herba Artemisiae Scopariae 20, Radix Et Rhizoma Rhei 10, Radix Glycyrrhizae 10, Poria 10, the Rhizoma Pinelliae 7, Radix Scutellariae 20, Rhizoma Cyperi 7, Fructus Aurantii Immaturus 18, the Rhizoma Atractylodis Macrocephalae 25, Cortex Magnoliae Officinalis 20, Endothelium Corneum Gigeriae Galli 22, Pericarpium Citri Reticulatae 25, Radix Raphani 20, Fructus Hordei Germinatus 35, Massa Medicata Fermentata 40, Fructus Crataegi (parched to brown) 75, its manufacture method is: get Herba Artemisiae Scopariae 20 by above-mentioned described ratio of weight and number, Radix Et Rhizoma Rhei 10, Radix Glycyrrhizae 10, Poria 10, the Rhizoma Pinelliae 7, Radix Scutellariae 20, Rhizoma Cyperi 7, Fructus Aurantii Immaturus 18, the Rhizoma Atractylodis Macrocephalae 25, Cortex Magnoliae Officinalis 20, Endothelium Corneum Gigeriae Galli 22, Pericarpium Citri Reticulatae 25, Radix Raphani 20, Fructus Hordei Germinatus 35, Massa Medicata Fermentata 40, Fructus Crataegi (parched to brown) 75, with each flavor Chinese medicine oven dry, bake out temperature is 60～80 ℃, be ground into fine flour afterwards, mix and add therein Mel, at 100～120 ℃ of refined honeys, cool to 80～100 ℃, make sweet face mix homogeneously, make honeyed pill by the Chinese Pharmacopoeia requirement, every ball 9 grams, each clothes two balls, ante cibum morning, with warm water delivery service (is that drink can improve curative effect with the ginger decoction), treating 50 days is a course of treatment after the supper.
Embodiment 4:
Special-purpose Chinese medicine of treatment chronic atrophic gastritis and preparation method thereof is treated the example of 1889 among the chronic atrophic gastritis patient who makes a definite diagnosis with this medicine, each two ball of twice morning and evening of every day, and the ginger decoction water delivery service 50 days was a course of treatment; Take this medicine man 590 examples, account for 31.23% of total number of persons, women 1299 examples account for 68.7% of total number of persons, add up to 1889 examples, account for 54.9% of total number of persons, and the mean age is 43.8 years old, and patient's 1719 examples of the stifled pain of pit of the stomach symptom are arranged, and its symptom has and significantly accounts for 91%; Patient's 1619 examples of full feeling symptom are arranged, and what its symptom had clear improvement accounts for 85.7%; Patient's 1606 examples of belch symptom are arranged, and what its symptom had clear improvement accounts for 85%; Patient's 1409 examples of indigestion and loss of appetite symptom are arranged, and what its symptom had clear improvement accounts for 74.6%; Become thin patient's 1020 examples of symptom of yellowish complexion are arranged, and what its symptom had clear improvement accounts for 54%,
Embodiment 5:
Special-purpose Chinese medicine of treatment chronic atrophic gastritis and preparation method thereof, the biopsy pathology section is carried out in patient's gastroscopy of 388 routine chronic atrophic gastritis simultaneously, after wherein having 126 routine patients (account for sum 20.5%) to take 50 days (course of treatment) of this medicine treatment, carry out the gastroscope check, its pathological change situation is observed in biopsy, and statistical result shows: intestinal epithelial metaplasia I～II
0Treat preceding 324 examples, account for 83.5% of total number of persons, wherein have pathology to improve after the 63 example treatments, account for 50% of treatment number; To atypical hyperplasia I～II
0Preceding 64 examples of sick treatment account for 16.5% of sum, and pathology 60 examples that made moderate progress in treatment back account for total 47.6%; To not having case before the no change pathology treatment, there are 3 routine no change pathology to improve after the treatment, account for 2.38% of sum.
Claims (2)
1. a Chinese medicine for the treatment of chronic atrophic gastritis is characterized in that the raw medicinal material and the consumption proportion that constitute this herbal medicine efficacy composition are: Herba Artemisiae Scopariae 15～30, Radix Et Rhizoma Rhei 5～15, Radix Glycyrrhizae 5～12, Poria 9～15, the Rhizoma Pinelliae 5～10, Radix Scutellariae 13～30, Rhizoma Cyperi 5～10, Fructus Aurantii Immaturus 15～20, the Rhizoma Atractylodis Macrocephalae 12～50, Cortex Magnoliae Officinalis 5～30, Endothelium Corneum Gigeriae Galli 15～25, Pericarpium Citri Reticulatae 20～30, Radix Raphani 10～25, Fructus Hordei Germinatus 25～50, Massa Medicata Fermentata 25～55, Fructus Crataegi (parched to brown) 50～100.
2. the manufacture method of the special-purpose Chinese medicine of the described treatment chronic atrophic gastritis of a claim 1, it is characterized in that: get Herba Artemisiae Scopariae 15～30 by above-mentioned described ratio of weight and number, Radix Et Rhizoma Rhei 5～15, Radix Glycyrrhizae 5～12, Poria 9～15, the Rhizoma Pinelliae 5～10, Radix Scutellariae 13～30, Rhizoma Cyperi 5～10, Fructus Aurantii Immaturus 15～20, the Rhizoma Atractylodis Macrocephalae 12～50, Cortex Magnoliae Officinalis 5～30, Endothelium Corneum Gigeriae Galli 15～25, Pericarpium Citri Reticulatae 20～30, Radix Raphani 10～25, Fructus Hordei Germinatus 25～50, Massa Medicata Fermentata 25～55, Fructus Crataegi (parched to brown) 50～100, with each flavor Chinese medicine oven dry, bake out temperature is 60～80 ℃, be ground into fine flour afterwards, mix and add therein Mel, at 100～120 ℃ of refined honeys, cool to 80～100 ℃, make sweet face mix homogeneously, make honeyed pill, every ball 9 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100438440A CN1330361C (en) | 2004-08-30 | 2004-08-30 | Chinese medicine special for treating chronic atrophic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100438440A CN1330361C (en) | 2004-08-30 | 2004-08-30 | Chinese medicine special for treating chronic atrophic gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1742952A CN1742952A (en) | 2006-03-08 |
| CN1330361C true CN1330361C (en) | 2007-08-08 |
Family
ID=36138577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100438440A Expired - Fee Related CN1330361C (en) | 2004-08-30 | 2004-08-30 | Chinese medicine special for treating chronic atrophic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1330361C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101766782B (en) * | 2010-04-08 | 2011-06-15 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicine composite for treating chronic gastritis and preparation method thereof |
| CN102940846B (en) * | 2012-12-08 | 2014-08-27 | 滨州医学院烟台附属医院 | Traditional Chinese medicine composition for treating atrophic gastritis as welln as preparation method and application of composition |
| CN104189640A (en) * | 2014-08-29 | 2014-12-10 | 广西博士海意信息科技有限公司 | Traditional Chinese medicine for treating stomach illness |
| CN104288400A (en) * | 2014-10-14 | 2015-01-21 | 王海霞 | Traditional Chinese medicine for treating gastrolithiasis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080534A (en) * | 1992-06-29 | 1994-01-12 | 韩保生 | Treatment atrophic gastritis Chinese medicine production method |
| CN1404846A (en) * | 2001-08-07 | 2003-03-26 | 李树军 | Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof |
-
2004
- 2004-08-30 CN CNB2004100438440A patent/CN1330361C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080534A (en) * | 1992-06-29 | 1994-01-12 | 韩保生 | Treatment atrophic gastritis Chinese medicine production method |
| CN1404846A (en) * | 2001-08-07 | 2003-03-26 | 李树军 | Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 中医治疗慢性萎缩性胃炎近况 唐存雄，广西中医药，第20卷第6期 1997 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1742952A (en) | 2006-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988870A (en) | Oral liquid for treating diseases of liver, gall, stomach and intestinal canal | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN104491755A (en) | Traditional Chinese medicine composition for treating abdominal distension and preparation method of traditional Chinese medicine composition | |
| WO2022143466A1 (en) | Medicinal and edible plant-based traditional chinese medicine composition for preventing cancers | |
| CN102488789A (en) | Chinese medicinal composition treating bile reflux gastritis and its preparation method | |
| CN1528408A (en) | Kangning Stomach invigorating capsule | |
| CN104162129A (en) | Traditional Chinese medicine for treating diabetic gastroparesis | |
| CN1330361C (en) | Chinese medicine special for treating chronic atrophic gastritis | |
| CN103055257B (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
| CN109718353A (en) | The traditional Chinese medicine pill and preparation method thereof for treating constipation | |
| CN105381420A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN101647961A (en) | Medicament for gastric cancer and esophagus cancer during postoperation and chemotherapy and preparation method thereof | |
| CN100509041C (en) | Stomach-clearing pill | |
| CN108888735B (en) | A kind of traditional Chinese medicine composition for treating chronic constipation | |
| CN105796685A (en) | Method for preparing traditional Chinese medicine composition for treating myocardial infarction | |
| CN104984141A (en) | Prescription for treating constipation and preparation method thereof | |
| CN109331166A (en) | A kind of Chinese medicine composition and preparation method thereof for treating stomach trouble | |
| KR102692595B1 (en) | Composition for treating and preventing constipation comprising Angelica gigas extract as an active ingredient | |
| CN103100026B (en) | Traditional Chinese medicine composition for treating postoperative dyspepsia and sour regurgitation caused by gastrectomy and preparation method thereof | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN101683469A (en) | Traditional Chinese medicine formula for treating dysentery | |
| CN106038887A (en) | Traditional Chinese medicine for treating stomach disease with middle-jiao cold and dampness and upper-jiao fire syndrome | |
| CN117281880A (en) | Traditional Chinese medicine composition for treating gastric precancerous lesions and preparation method and application thereof | |
| CN118873617A (en) | A Chinese medicine composition for treating esophageal cancer and its preparation method and application | |
| CN116617346A (en) | A Chinese medicinal composition for treating gastropathy, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |